Salcaprozate Sodium as a Permeation Enhancer—Mechanism, Applications and Unresolved Questions

作者
Boris Dinkov,Nikolinka Koleva,Galya Stavreva
出处
期刊:Pharmaceutics [Multidisciplinary Digital Publishing Institute]
卷期号:18 (9): 1171-1171
标识
DOI:10.3390/pharmaceutics18091171
摘要

Oral absorption remains challenging for peptides, proteins, and other drug substances with limited stability or permeability. Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC), also known as salcaprozate sodium, is an oral permeation enhancer used in approved drug products. This review summarizes the physicochemical properties and mechanisms of action of SNAC and evaluates its clinical and emerging preclinical applications. A structured literature search was conducted in PubMed and Scopus, supplemented as needed with ClinicalTrials.gov and regulatory documents. The search covered 2015-2026, with earlier key publications included where necessary for historical context. After screening, 71 sources were included in the narrative synthesis. The review examines the proposed mechanisms of SNAC-mediated permeation enhancement, including local pH modulation, membrane-mediated effects, peptide self-association, and context-dependent effects on epithelial permeability. Clinical evidence is summarized for oral semaglutide, cyanocobalamin, unfractionated heparin, ibandronate, and investigational peptide products. Emerging applications beyond metabolic diseases are discussed together with formulation strategies and safety considerations. Recent preclinical findings suggesting changes in gut microbiota and inflammatory markers are critically evaluated in the context of the available clinical safety experience, while their relevance to humans remains unconfirmed. Overall, SNAC reliably enhances permeation in vitro and in vivo, yet the resulting oral bioavailability remains low and variable and is strongly dependent on payload, formulation, and gastrointestinal conditions. Long-term safety and the clinical relevance of recent preclinical microbiome findings remain important areas for future investigation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小阿斗发布了新的文献求助30
刚刚
sarah完成签到,获得积分10
1秒前
SciGPT的应助被Yvette2024采纳,获得10
2秒前
凌晨发布了新的文献求助10
2秒前
斯文败类的应助被JackBear采纳,获得10
2秒前
2秒前
2秒前
3秒前
aaaaaa完成签到,获得积分10
3秒前
bkagyin的应助被Imin采纳,获得10
3秒前
科研通AI6.4的应助被实验狗采纳,获得10
3秒前
三木发布了新的文献求助10
5秒前
5秒前
SHMILY414完成签到,获得积分10
5秒前
马邦德完成签到,获得积分10
5秒前
关关九九发布了新的文献求助10
5秒前
定格完成签到,获得积分10
5秒前
tina酱完成签到 ,获得积分10
6秒前
6秒前
CodeCraft的应助被kiara采纳,获得10
6秒前
藤井树发布了新的文献求助10
7秒前
共享精神的应助被土豪的橘子采纳,获得10
7秒前
wocc给勤劳的易绿的求助进行了留言
8秒前
8秒前
刘璞完成签到,获得积分10
9秒前
李爱国的应助被HHHH采纳,获得30
9秒前
神勇的芸发布了新的文献求助10
10秒前
小巧雪碧完成签到 ,获得积分10
10秒前
10秒前
qqasd完成签到,获得积分10
11秒前
zzzzz完成签到,获得积分10
11秒前
11秒前
uu完成签到,获得积分20
11秒前
科目三的应助被黑猫黑猫采纳,获得10
13秒前
蓝星完成签到,获得积分10
13秒前
xfy的应助被科研通管家采纳,获得20
14秒前
14秒前
科研板砖完成签到,获得积分20
14秒前
wanci的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160526
求助须知:如何正确求助?哪些是违规求助? 9555475
关于积分的说明 21728510
捐赠科研通 7750342
什么是DOI,文献DOI怎么找? 3427395
关于科研通互助平台的介绍 2552448
邀请新用户注册赠送积分活动 2471795